The Histone‐Deacetylase‐Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase‐13 Activity

Direct application of histone‐deacetylase‐inhibitors (HDACis) to dental pulp cells (DPCs) induces chromatin changes, promoting gene expression and cellular‐reparative events. We have previously demonstrated that HDACis (valproic acid, trichostatin A) increase mineralization in dental papillae‐derived cell‐lines and primary DPCs by stimulation of dentinogenic gene expression. Here, we investigated novel genes regulated by the HDACi, suberoylanilide hydroxamic acid (SAHA), to identify new pathways contributing to DPC differentiation. SAHA significantly compromised DPC viability only at relatively high concentrations (5 μM); while low concentrations (1 μM) SAHA did not increase apoptosis. HDACi‐exposure for 24 h induced mineralization‐per‐cell dose‐dependently after 2 weeks; however, constant 14d SAHA‐exposure inhibited mineralization. Microarray analysis (24 h and 14 days) of SAHA exposed cultures highlighted that 764 transcripts showed a significant >2.0‐fold change at 24 h, which reduced to 36 genes at 14 days. 59% of genes were down‐regulated at 24 h and 36% at 14 days, respectively. Pathway analysis indicated SAHA increased expression of members of the matrix metalloproteinase (MMP) family. Furthermore, SAHA‐supplementation increased MMP‐13 protein expression (7 d, 14 days) and enzyme activity (48 h, 14 days). Selective MMP‐13‐inhibition (MMP‐13i) dose‐dependently accelerated mineralization in both SAHA‐treated and non‐treated cultures. MMP‐13i‐supplementation promoted expression of several mineralization‐associated markers, however, HDACi‐induced cell migration and wound healing were impaired. Data demonstrate that short‐term low‐dose SAHA‐exposure promotes mineralization in DPCs by modulating gene pathways and tissue proteases. MMP‐13i further increased mineralization‐associated events, but decreased HDACi cell migration indicating a specific role for MMP‐13 in pulpal repair processes. Pharmacological inhibition of HDAC and MMP may provide novel insights into pulpal repair processes with significant translational benefit. J. Cell. Physiol. 231: 798–816, 2016. © 2015 Wiley Periodicals, Inc.

[1]  B. Hille,et al.  Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support , 2016, PloS one.

[2]  J. Ahn,et al.  Solute Carrier Organic Anion Transporter Family Member 4A1 (SLCO4A1) in Colorectal Cancer , 2016 .

[3]  S. Harris,et al.  Establishment of Immortalized Mouse Bmp2 Knock‐Out Dental Papilla Mesenchymal Cells Necessary for Study of Odontoblastic Differentiation and Odontogenesis , 2015, Journal of cellular physiology.

[4]  M. McBurney,et al.  Sirtuin 1 Is a Negative Regulator of Parathyroid Hormone Stimulation of Matrix Metalloproteinase 13 Expression in Osteoblastic Cells , 2015, The Journal of Biological Chemistry.

[5]  J. Granjeiro,et al.  Bone tissue remodeling and development: focus on matrix metalloproteinase functions. , 2014, Archives of biochemistry and biophysics.

[6]  N. Mahmud,et al.  Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  L. Altucci,et al.  Histone Deacetylase Inhibition with Valproic Acid Downregulates Osteocalcin Gene Expression in Human Dental Pulp Stem Cells and Osteoblasts: Evidence for HDAC2 Involvement , 2014, Stem cells.

[8]  Junlin Qi,et al.  Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy , 2013, Disease Models & Mechanisms.

[9]  Lucas R. Smith,et al.  Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration. , 2013, American journal of physiology. Cell physiology.

[10]  Y. Li,et al.  Histone Deacetylase Inhibition Promotes Osteoblast Maturation by Altering the Histone H4 Epigenome and Reduces Akt Phosphorylation* , 2013, The Journal of Biological Chemistry.

[11]  Yan Wang,et al.  MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. , 2013, Toxicology letters.

[12]  Benjamin E. L. Lauffer,et al.  Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability , 2013, The Journal of Biological Chemistry.

[13]  M. Capogrossi,et al.  Enhancement of lysine acetylation accelerates wound repair , 2013, Communicative & integrative biology.

[14]  P. Huang,et al.  CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells. , 2013, International endodontic journal.

[15]  A. Kolokythas,et al.  Epigenetic marks define the lineage and differentiation potential of two distinct neural crest-derived intermediate odontogenic progenitor populations. , 2013, Stem cells and development.

[16]  H. Duncan,et al.  Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells. , 2013, Experimental cell research.

[17]  B. Turner,et al.  The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing , 2013, Epigenetics & Chromatin.

[18]  P. Croucher,et al.  Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo , 2013, Acta Pharmacologica Sinica.

[19]  C. Cellai,et al.  Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells , 2013, PloS one.

[20]  P. Choung,et al.  HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. , 2013, Tissue engineering. Part A.

[21]  E. Patsouris,et al.  Current evidence for histone deacetylase inhibitors in pancreatic cancer. , 2013, World journal of gastroenterology.

[22]  R. Raghow,et al.  Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells , 2012, BMC Genomics.

[23]  R. Shelton,et al.  Recruitment of dental pulp cells by dentine and pulp extracellular matrix components. , 2012, Experimental cell research.

[24]  H. Kiyonari,et al.  Osterix Regulates Calcification and Degradation of Chondrogenic Matrices through Matrix Metalloproteinase 13 (MMP13) Expression in Association with Transcription Factor Runx2 during Endochondral Ossification* , 2012, The Journal of Biological Chemistry.

[25]  C. Chen,et al.  HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy , 2012, Clinical Cancer Research.

[26]  H. Ryoo,et al.  Suberoylanilide Hydroxamic Acid Enhances Odontoblast Differentiation , 2012, Journal of dental research.

[27]  H. Duncan,et al.  Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. , 2012, Journal of endodontics.

[28]  W. Bloch,et al.  Histone deacetylases 2 and 9 are coexpressed and nuclear localized in human molar odontoblasts in vivo , 2012, Histochemistry and Cell Biology.

[29]  Chris T. A. Evelo,et al.  WikiPathways: building research communities on biological pathways , 2011, Nucleic Acids Res..

[30]  H. Duncan,et al.  HDACi , 2011, Journal of dental research.

[31]  G. Stein,et al.  Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts. , 2011, Bone.

[32]  Jennifer J Westendorf,et al.  Histone deacetylases in skeletal development and bone mass maintenance. , 2011, Gene.

[33]  Sarah G. Bailey,et al.  Histone Deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases. , 2010, Current drug targets.

[34]  P. Marks Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. , 2010, Biochimica et biophysica acta.

[35]  Minnkyong Lee,et al.  Parathyroid Hormone Activation of Matrix Metalloproteinase-13 Transcription Requires the Histone Acetyltransferase Activity of p300 and PCAF and p300-dependent Acetylation of PCAF* , 2010, The Journal of Biological Chemistry.

[36]  F. Flamigni,et al.  Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors. , 2010, Arthritis and rheumatism.

[37]  N. Hukriede,et al.  Inhibition of histone deacetylase expands the renal progenitor cell population. , 2010, Journal of the American Society of Nephrology : JASN.

[38]  D. Musson,et al.  Adrenomedullin is expressed during rodent dental tissue development and promotes cell growth and mineralization , 2010, Biology of the cell.

[39]  E. Olson,et al.  HDAC4 Represses Matrix Metalloproteinase-13 Transcription in Osteoblastic Cells, and Parathyroid Hormone Controls This Repression* , 2010, The Journal of Biological Chemistry.

[40]  Susan Groshen,et al.  DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines , 2009, BMC Medical Genomics.

[41]  Allan Kuchinsky,et al.  Alternative Splicing in the Differentiation of Human Embryonic Stem Cells into Cardiac Precursors , 2009, PLoS Comput. Biol..

[42]  C. Bagni,et al.  Acetylation of RTN-1C regulates the induction of ER stress by the inhibition of HDAC activity in neuroectodermal tumors , 2009, Oncogene.

[43]  P. Cooper,et al.  Phenotype and behaviour of dental pulp cells during expansion culture. , 2009, Archives of oral biology.

[44]  I. Fichtner,et al.  Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models. , 2009, International journal of oncology.

[45]  Joan W. Miller,et al.  Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications. , 2009, Investigative ophthalmology & visual science.

[46]  T. Nakajima,et al.  MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. , 2009, The American journal of pathology.

[47]  J. Eun,et al.  Systemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells. , 2009, International journal of molecular medicine.

[48]  W-S Xu,et al.  Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.

[49]  L. Zolla,et al.  A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. , 2008, Biochimica et biophysica acta.

[50]  Chris T. A. Evelo,et al.  Presenting and exploring biological pathways with PathVisio , 2008, BMC Bioinformatics.

[51]  J. Keen,et al.  Trichostatin A and 5 Aza-2′ deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR , 2008, Breast Cancer Research and Treatment.

[52]  E. Gagari,et al.  Expression of MMP-13 (collagenase-3) in long-term cultures of human dental pulp cells. , 2008, Archives of oral biology.

[53]  S. Krane,et al.  Matrix metalloproteinases and bone. , 2008, Bone.

[54]  Robert W. Li,et al.  Butyrate Induced Cell Cycle Arrest in Bovine Cells through Targeting Gene Expression Relevant to DNA Replication Apparatus , 2008, Gene regulation and systems biology.

[55]  P. Cooper,et al.  Dental regeneration and materials—a partnership , 2008, Clinical Oral Investigations.

[56]  P. Finn,et al.  Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. , 2008, The Biochemical journal.

[57]  J. S. Rao,et al.  Inhibition of Histone Deacetylase Activity Promotes Invasion of Human Cancer Cells through Activation of Urokinase Plasminogen Activator* , 2007, Journal of Biological Chemistry.

[58]  Z. Werb,et al.  Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration , 2007, PloS one.

[59]  J. Westendorf,et al.  Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors , 2007, BMC Genomics.

[60]  S. Reppe,et al.  Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and Metabolism , 2007, Epilepsia.

[61]  L. Grover,et al.  Dissolution of bio-active dentine matrix components by mineral trioxide aggregate. , 2007, Journal of dentistry.

[62]  F. García-Godoy,et al.  Regenerative endodontics: a review of current status and a call for action. , 2007, Journal of endodontics.

[63]  C. Hansch,et al.  Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. , 2007, Bioorganic & medicinal chemistry.

[64]  M. Szyf,et al.  Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. , 2007, Carcinogenesis.

[65]  T. Nagashima,et al.  Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. , 2007, Endocrinology.

[66]  H. Quentmeier,et al.  Epigenetic regulation of brain expressed X-linked-2, a marker for acute myeloid leukemia with mixed lineage leukemia rearrangements , 2007, Leukemia.

[67]  Leo Tjäderhane,et al.  The role of matrix metalloproteinases in the oral environment , 2007, Acta odontologica Scandinavica.

[68]  N. Belyaev,et al.  BRG1 Chromatin Remodeling Activity Is Required for Efficient Chromatin Binding by Repressor Element 1-silencing Transcription Factor (REST) and Facilitates REST-mediated Repression* , 2006, Journal of Biological Chemistry.

[69]  L. Guarente,et al.  Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. , 2006, Genes & development.

[70]  C. V. van Blitterswijk,et al.  Inhibition of histone acetylation as a tool in bone tissue engineering. , 2006, Tissue engineering.

[71]  Jessica E. Bolden,et al.  Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.

[72]  Timothy C Ryken,et al.  Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. , 2006, Cancer research.

[73]  J. Westendorf,et al.  Histone Deacetylase Inhibitors Promote Osteoblast Maturation , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[74]  P. Marks,et al.  Histone deacetylase inhibitors: discovery and development as anticancer agents , 2005, Expert opinion on investigational drugs.

[75]  Hyunjin Cho,et al.  Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors , 2005, Journal of cellular biochemistry.

[76]  Ding‐Shinn Chen,et al.  Epigenetic activation of α4, β2 and β6 integrins involved in cell migration in trichostatin A-treated Hep3B cells , 2005 .

[77]  T. Yamano,et al.  Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. , 2005, Cancer research.

[78]  Mahboob Rahman,et al.  Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[79]  H. Yoo,et al.  Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray. , 2004, Biological & pharmaceutical bulletin.

[80]  A. Scarpa,et al.  Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. , 2004, Biochimica et biophysica acta.

[81]  R. Ala-aho,et al.  Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo , 2004, Oncogene.

[82]  D. Prockop,et al.  An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. , 2004, Analytical biochemistry.

[83]  Ivan V. Gregoretti,et al.  Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. , 2004, Journal of molecular biology.

[84]  Y. Sowa,et al.  Trichostatin A activates the osteopontin gene promoter through AP1 site. , 2004, Biochemical and biophysical research communications.

[85]  T. Salo,et al.  Matrix Metalloproteinase-13 (MMP-13, Collagenase-3) is Highly Expressed in Human Tooth Pulp , 2004, Connective tissue research.

[86]  Yang Shi,et al.  Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt Pathway* , 2003, Journal of Biological Chemistry.

[87]  Z. Werb,et al.  How Proteases Regulate Bone Morphogenesis , 2003, Annals of the New York Academy of Sciences.

[88]  F. Dequiedt,et al.  Class II histone deacetylases: versatile regulators. , 2003, Trends in genetics : TIG.

[89]  T. Salo,et al.  Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue. , 2003, European journal of oral sciences.

[90]  M. King Preserving the vital pulp in operative dentistry. , 2002, Dental update.

[91]  H. V. Van Wart,et al.  Proteolysis Involving Matrix Metalloproteinase 13 (Collagenase‐3) Is Required for Chondrocyte Differentiation That Is Associated with Matrix Mineralization , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[92]  E. Jansen,et al.  Real-time visualization of MMP-13 promoter activity in transgenic mice. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[93]  P. Lumley,et al.  Preserving the vital pulp in operative dentistry: I. A biological approach. , 2002, Dental update.

[94]  Thiennu H. Vu,et al.  Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.

[95]  Jiahuai Han,et al.  Transforming Growth Factor-β Induces Collagenase-3 Expression by Human Gingival Fibroblasts via p38 Mitogen-activated Protein Kinase* , 1999, The Journal of Biological Chemistry.

[96]  S. Bloch,et al.  Regulation of expression of collagenase‐3 in normal, differentiating rat osteoblasts , 1999, Journal of cellular physiology.

[97]  H. Takahashi,et al.  Expression of metalloproteinase-13 (Collagenase-3) is induced during fracture healing in mice. , 1999, Bone.

[98]  C. Murphy,et al.  Effect of Norepinephrine on Proliferation, Migration, and Adhesion of SV‐40 Transformed Human Corneal Epithelial Cells , 1998, Cornea.

[99]  M. Iwaku,et al.  Immunolocalization of Fibronectin during Reparative Dentinogenesis in Human Teeth after Pulp Capping with Calcium Hydroxide , 1996, Journal of dental research.

[100]  U. Schröder Effects of Calcium Hydroxide-containing Pulp-capping Agents on Pulp Cell Migration, Proliferation, and Differentiation , 1985, Journal of dental research.

[101]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[102]  J. Ricker,et al.  Vorinostat , 2017, Reactions Weekly.

[103]  S. Imazato,et al.  Activation of the Wnt/β-catenin pathway and tissue inhibitor of metalloprotease 1 during tertiary dentinogenesis. , 2013, Journal of biochemistry.

[104]  M. Swain,et al.  Regulation of reactionary dentin formation by odontoblasts in response to polymicrobial invasion of dentin matrix. , 2012, Bone.

[105]  M. McGee-Lawrence,et al.  Hdac-mediated control of endochondral and intramembranous ossification. , 2011, Critical reviews in eukaryotic gene expression.

[106]  R. Kizek,et al.  Matrix metalloproteinases. , 2010, Current medicinal chemistry.

[107]  P. Atadja,et al.  The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance , 2009, Nature Immunology.

[108]  J. Heino,et al.  Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes survival of human skin fibroblasts. , 2007, The Journal of investigative dermatology.

[109]  Ding‐Shinn Chen,et al.  Epigenetic activation of alpha4, beta2 and beta6 integrins involved in cell migration in trichostatin A-treated Hep3B cells. , 2005, Journal of biomedical science.

[110]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[111]  H. Lesot,et al.  Reactionary dentinogenesis. , 1995, The International journal of developmental biology.

[112]  K. Staines,et al.  Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling , 2014, Journal of Bone and Mineral Metabolism.